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Abstract
Approximately 1-2% of patients have complications due to bacterial infection.
Staphylococcus aureus, Staphylococcus epidermidis and Pseudomonas aeruginosa are
the three bacteria responsible for approximately 75% of biofilm-related infections. These
three microorganisms can adhere to stainless steel and orthopedic screws. Biofilms are
produced by an accumulation of bacteria which can attach to a surface, accumulate and
form an extracellular polymeric substance.
Green tea extracts from plant Camellia sinensis have long been studied for their
antimicrobial effect on gram-positive and gram-negative bacteria. Polyphenols found in
green tea, specifically epigallocatechin-gallate (EGCG), are the most important
component in targeting biofilm. However, this compound can be readily oxidized and is
therefore unstable. Previous studies have shown that the modified lipophilic compound,
epigallocatechin-gallate-stearate (EGCG-S), can inhibit biofilm formation and decrease
cell viability.
The purpose of this study was to evaluate if EGCG-S could play a role in
targeting prosthetic joint infection caused by Staphylococcus aureus, Staphylococcus
epidermidis and Pseudomonas aeruginosa. Major goals of this study were to determine if
EGCG-S could enhance the current treatment method and inhibit biofilm in addition to
two virulent factors. The minimum time frame was also determined for treatment to be
most effective. EGCG-S was shown to have some inhibitory effects on colony forming
units, the most effective time for treatment was observed starting at five minutes. The tea
polyphenol was also able to inhibit biofilm and protease and elastase when the three
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bacteria were in combination. EGCG-S shows potential for combating acute and chronic
joint arthroplasty infections.
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Introduction
The wear and tear of everyday activities is extremely burdensome on joints.
Osteoarthritis, a degenerative joint disease caused by wearing and tearing of the
breakdown of cartilage covering the ends of bones in joints is due to chronic
inflammation. In this disease, tissues such as cartilage start to erode away, causing an
immense amount of pain, discomfort and overall debilitation (Song et al., 2013). With the
current population’s life expectancy on the rise, osteoarthritis has become the fourth most
common cause of hospitalization in 2009. The end result of osteoarthritis after failed
conservative methods is usually joint replacement surgery (Song et al., 2013) Thus, there
has been an increase in orthopedic surgery for prosthetic joint implantations.
Advancements in joint implantations have allowed individuals to regain their
mobility and overall physical function. In 2005 there were 572,000 and 3.48 million cases
of hip and knee replacement surgeries, respectively. It was estimated then that by 2030
the need for primary total hip arthroplasties and total knee arthroplasties would be
projected to grow by 174% and 673% (Kurtz et al., 2007). Due to increased knowledge in
healthcare and technological innovations, the amount of prosthetic joint implantations has
tremendously increased in orthopedic medicine. In 2010 there were over one million total
knee and hip arthroplasties. Additionally, Tande and Patel (2014), suggest that the total
number or surgical interventions will increase to 5 million by 2030, more than was
originally predicted.
As the incidence rises there are minimal risks; however, one of the side-effects is
bacterial infection due to aseptic or septic failure (Kasch et al., 2016). Infections can be
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classified as early, delayed, or late onset of symptoms after implantation; early being
within three months of a patient’s last surgery, delayed occurring after three months but
before two years post-surgery, and late occurring past a two-year time period (Tande &
Patel, 2014). Infections can also be classified according to their route of entry such as
perioperative, hematogenous, and contiguous. Perioperative suggests that infection is due
to the inoculation of the microorganisms during surgery or immediately after. Patients
who are immunosuppressed tend to be at higher risk for perioperative infections.
Haemateogenous infection means the infection has spread through blood or lymph.
Contiguous infection is one that spreads from an adjacent focus of the infection, such as a
penetrating trauma, osteomyelitis, skin or soft tissue lesions (Trampuz & Zimmerli,
2005).
Causative agents of these infections are usually gram-positive staphylococcus and
streptococcus (Rodríguez-Merchán & Liddle, 2018). Gram-negative bacteria also
constitute 10-23% of infectious episodes that are acute (Rodríguez-Pardo et al., 2014).
Staphylococcus aureus is a microorganism that is largely responsible for prosthetic joint
infections, followed by coagulase-negative staphylococci, such as Staphylococcus
epidermidis (Tandel & Patel, 2014). Aerobic gram-negative bacteria such as
Pseudomonas aeruginosa is another dominant bacterium responsible for infections
(Stover et al., 2000). Humans are natural reservoirs for these three bacteria. These
bacteria reside in patient’s blood, nasal passages, and skin. When combined, these
polymicrobial prosthetic join infections can occur in up to 35% of early onset infections
(Tande & Patel, 2014).
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Staphylococcus aureus, Staphylococcus epidermidis and Pseudomonas
aeruginosa are the three predominant bacteria responsible for approximately 75% of
biofilm-related infections in prosthesis. These three opportunistic microorganisms have
the ability to adhere to metals such as cobalt-chromium, titanium, polyethylene, and
polymethylmethacrylate (PMMA) cement which are commonly used in implants, and
orthopedic screws creating a biofilm (Song et al., 2013; Nana et al., 2016). Biofilm
formation is due to a unique interaction of unicellular organisms that are encompassed in
an extracellular matrix of polysaccharides, proteins, and nucleic acids (Fey & Olson.,
2010). Biofilm formation is broken down into four steps: adherence, accumulation,
maturation and detachment (Fey & Olson, 2010). The clusters of microorganisms living
closely together in this matrix depletes metabolic substances and increases products,
allowing the accumulation to cause the microbes to enter a slow or non-growing stage.
Thus, the microorganisms are up to 1,000 times more resistant to antimicrobial treatments
than if they were freely living on their own. Their complex structure allows for interstitial
water channels in which nutrients can circulate, forming a system similar to a circulatory
system which then allows for the release of cell to cell signaling molecules known as
quorum sensing. Quorum sensing allows bacteria in a population to respond to changes in
gene expression, thus allowing the biofilm to differentiate (Trampuz & Zimmerli., 2005).
Additionally, quorum sensing can cause transcriptional changes, which can lead to
expression of virulence factors and antibiotic resistance (Nana et al.,2016).
Gram-positive and negative bacteria use different types of quorum sensing
systems. One system gram-positive bacteria use is through peptides called autoinducing
peptides. Gram negative bacteria communicate using extracellular signaling molecules
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called autoinducers (Rutherford & Bassler., 2012). Common virulence factors produced
by these bacteria are protease and elastase, which help with the quorum sensing to form
biofilms. Proteases are produced by wide variety of microbes, which are not only
resistant to human plasma protease inhibitors but can inactivate these inhibitors thus
accelerating the infection process (Maeda,1996). Elastase, an enzyme in the class of
proteases, breaks down elastin and elastic fibers. Neutrophil elastase has been shown to
impair host defense against infection by degrading phagocyte surface receptors and
opsonins produced by bacteria (Hiemstra, 2002). Proteases are important in tissue
damage caused by P. aeruginosa infection. P. aeruginosa secretes alkaline protease and
two elastases (A and B) have been characterized as exoenzymes and virulence factors
(Engel et al. 1998). Pavlovskis and Wretlind (1979) found that protease enhances the
virulence of P. aeruginosa and is a contributing factor to the invasiveness of the
pathogen. S. epidermidis and S. aureus, have a similar core genome, although S. aureus is
usually associated as more virulent than S. epidermidis. S. epidermidis, encodes fewer
known and putative virulence factors and pathogenicity islands in comparison to S.
aureus. Some of the virulence factors produced by S. epidermidis are serine protease,
cysteine protease, elastase, and Clp protease (Fey & Olson, 2010). Therefore, one
mechanism to inhibit biofilm formation would be to inhibit these virulence factors in
order to prevent cell attachment or aggregation on the device.
S. aureus produces various enzymes that clot plasma and coat the bacterial cell,
which helps evade the immune system response by preventing phagocytosis. One enzyme
that does this is coagulase. Another enzyme produced by S. aureus is hyaluronidase,
which breaks down hyaluronic acid, and helps spread the bacteria. S. aureus also
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produced exotoxins that can promote its virulence. Costerton, Montanaro, and Ariola
(2005) suggest that biofilm formation in staphylococcus bacteria is a polymer β-1,6linked N-acetylglucosamine (PIA), whose synthesis is mediated by the ica operon. Ruiz
de los Mozos (2013) targeted a long 3′-untranslated region of icaR, which codes for the
repressor of the main exopolysaccharide compound of the S. aureus biofilm matrix and
found that deletion or substitution in a specific area resulted in inhibition of biofilm
formations. Other proteins that have been associated with biofilm formation in
staphylococcal bacteria are accumulationassociated protein (AAP), the clumping factor
A (ClfA), the staphylococcal surface protein (SSP1) and the biofilmassociated protein
(Bap) (Gotz., 2002).
Pseudomonas aeruginosa is also considered a successful opportunistic pathogen
because it produced a myriad of virulence factors such as exoproteases, siderophores,
exotoxins, and lipases. There are two quorum sensing systems in P. aeruginosa: LasR-I
and RhlR-I, with an additional LuxR homolog that is adjacent to a cluster of quorumsensing-controlled (qsc) genes. The target genes for these systems are lasB, toxA, rhIR,
and lasl (Parsek & Greenberg, 2000).
Although, 1% of prosthesis joint implantation become infected, this complication
is associated with higher morbidity and a substantial economic hardship. Treatment is
usually a two- stage procedure in which there is first the removal of the foreign material,
such as the implant and bone cement, followed by a course of antimicrobial treatment.
This conservative approach has a success rate for staphylococcal infections ranging from
55% to over 75% (Rodríguez-Pardo et al. 2014). Other surgical interventions include
debridement with retention, in which the surgical area is washed out and the implantation
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is kept in. The one stage direct exchange is the removal and implantation of a new
prosthesis. Lastly, the two-stage surgical intervention is removal of the prosthesis and
implantation of a new one, two to eight weeks later. Worst-case scenario would be
permanent removal of the device, which is usually done for patients with high risk of
reinfection such as those that are severely immunocompromised. Antimicrobial therapy is
suggested for a 3-month duration for hip prostheses and 6 months for knee. The most
used therapy is rifampicin for staphylococcal implant infections (Trampuz & Zimmerli,
2005).
Currently, the best way to resolve the issue of the burdensome biofilm is the
removal of the implanted device, a solution that is extremely expensive. Some new novel
approaches have been studied such as the use of green tea polyphenols. Green tea from
plant Camellia sinensis has long been studied for its antimicrobial effect in gram positive
and gram-negative bacteria (Reygaert, 2014). Green tea is a non-fermented tea, which
contains more catechins than other processed tea. Tea polyphenols are strong antioxidants
both in vitro and in vivo. Polyphenols, specifically flavonoids such as catechins are
present in green tea. The four major catechins are epigallocatechin-3-gallate (EGCG),
that represents approximately 59% of the total of catechins, epigallocatechin (EGC) (19%
approximately), epicatechin-3-gallate (ECG) (13.6% approximately), and epicatechin
(EC) (6.4% approximately) (Cabrera, Artacho & Giménez, 2006).
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It has been reported that the antimicrobial properties of EGCG are mediated
through its high affinity but nonspecific binding to viral surface proteins (Hsu,2015).
EGCG is a potential agent in treating bacterial infections because it is non-toxic.
However, when placed in an aqueous environment, it is readily oxidized and loses its
stability (Ping et al., 2003). Thus, it has been proposed that fatty acid modified
polyphenols, as through lipid esterification, could be effective. These enzymatic and
chemically altered compounds are referred to as lipid soluble tea polyphenols and are
more stable (Ali et al., 2017).
While many studies have shown that EGCG has effective antimicrobial effects,
there have not been sufficient studies in the host evading mechanisms of the bacteria due
to EGCG treatment. Tran et al (2014) completed a promising study in which they looked
at the minimum inhibitory concentration of EGCG that could interfere with quorum
sensing regulating factors such as protease, elastase, and pyocyanin produced by P.
aeruginosa and P.fluorescens. They found that as the concentration of EGCG increases,
there was a decrease in biofilm production in the two bacteria (Tran et al., 2014). The
Minimum Inhibitory Concentration for each organism was found to be 8 mM, which is
approximately 3.6 mg/mL of EGCG. Polyphenols found in green tea, specifically
18

epigallocatechin-gallate, are an important component in targeting biofilm. This study
seeks to expand on the current treatment method currently used by Dr. Alvin Ong and
other orthopedic surgeons at AlantiCare Regional Medical Center and Thomas Jefferson
University Hospital. A further elaboration on the study of Tran et al (2014), will also be
performed to evaluate the inhibitory effect of virulence factors in biofilm formation
using epigallocatechin-gallate-stearate (EGCG-S), a green tea polyphenol. It was
hypothesized that EGCG-S at a concentration of 250 μg/ml would have an enhancing
effect on the current treatment method and an inhibitory effect on protease and elastase
virulent factors in biofilm production of Staphylococcus aureus, Staphylococcus
epidermidis, Pseudomonas aeruginosa, and a combination of all three.
Objectives
1. Evaluate current prosthetic joint infection treatment method with EGCG-S.
2. Determine minimum synergistic time frame for antibiotics and EGCG-S.
3. Determine synergistic effect of EGCG-S on biofilm and two virulent factors.
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Materials and Methods
1. Culturing Bacteria
Three strains of bacteria were used: Staphylococcus aureus (S. aureus,)
Staphylococcus epidermidis (S.epidermidis) and Pseudomonas aeruginosa
(P.aeruginosa). Each strain was kept and maintained on a tryptic soy agar (TSA) plate.
The plates were stored in a refrigerator at 4oC and re-grown on new tryptic soy agar
plates every two weeks. Overnight cultures were made from the stock plates, by
obtaining a small amount of the bacteria (aseptically) with a cotton swab or inoculation
loop. After the sample was obtained, it was put into a tube with tryptic soy broth (TSB).
The samples with broth and bacteria were then labeled with the initials of the organism,
date and the experimenter’s name. Samples were then placed into a 250-rpm shaking
incubator at 37oC. The samples were removed from the incubator the next morning.
Before starting the experiment, the overnight cultures were checked for purity by
preforming a simple or gram stain.
2. Media Preparation
a. Tryptic Soy broth (TSB) preparation
Thirty grams of powder from DifcoTM was mixed with 1L of deionized (DI) water in a
2L Pyrex flask. The flask was labeled with tape for indication of the contents inside and
the experimenter’s name. Once mixture was mixed thoroughly (powder fully dissolved),
it was autoclaved on the liquid cycle for 30 minutes at 121oC. When the autoclave
process was complete the flask was allowed to cool and later placed in a 4 oC cold room
for storage.
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b. Tryptic Soy (TSA) and Muller Hinton Agar (MHA) preparation
Forty grams of tryptic soy powder from DifcoTM was dissolved in 2L flask with 1L of
deionized water. The flask was labeled and autoclaved at 121oC for 30 minutes. The flask
was allowed to cool to about 55-60 oC. Once cooled the liquid was poured into sterile
plates aseptically. The plates were kept under the hood, until they solidified. Once
solidified, plastic sleeves were used to store the plates for future use. The sleeves were
labeled with the name of the agar and placed in the cold room.
MHA plates were prepared for Disk diffusion studies by combining 1L of deionized
water with 38g of powder from DifcoTM. The solution was mixed and autoclaved at 121
o

C for 30 minutes. After cooling, the media was poured into sterile plates. Once the agar

solidified on the plates, they were put into sleeves, labeled and stored in the cold room for
future experiments.
3. Staining Techniques
a. Simple stain
A simple stain was performed on overnight cultures before the start of each
experiment to check for purity. A sterile loop was used to obtain a small sample. The
sample was then placed on a sterile microscope slide, heat fixed and stained with
methylene blue. A coverslip was placed on top of the sample and bibulous was used to
blot dry the slide. The slide was viewed under the oil immersion objective (1,000X) with
a compound microscope to observe cell morphologies (Lee et al., 2015).
b. Gram Stain
Gram stain was carried out to check and confirm the gram status and to determine
the morphology of the microorganisms to be used in the experiment. A sample was taken
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from TSA or TSB. If TSA was used a drop of DI water had to be placed on the slide. The
bacteria from the agar was then mixed in. Once a sample was placed on the slide it was
heat fixed. Crystal violet was then applied for 20 seconds and rinsed with DI water for 2
seconds. Gram’s iodine was added for 1 minute and washed off with Gram’s decolorizer
for 10-20 seconds. The decolorizer was then rinsed with DI water for 2 seconds and
safranin was applied for 1 minute. The safranin was rinsed with DI water and the slide
was blot dried with bibulous paper. Observation of the slide was done under a compound
microscope at 1,000X (Lee et al., 2015).
4. Preparation of treatments
a. Tea Polyphenols
EGCG-S was purchased from Camellix LLC, Augusta, GA. A stock of 10X 250 μg/mL
and 10X 500 μg/mL were prepared. The compounds were dissolved in 200 proof ethanol.
The stocks were stored in a -20°C freezer.
b. Antibiotics
Polymyxin B and Bacitracin, the two antibiotics currently used to treat joint infection at
Atlantic Regional Medical Center were prepared. The powders were purchased from
Sigma Aldrich. Masses of 0.00198 g of Polymyxin B and 0.00225 g of Bacitracin,
respectively, were weighed out and each dissolved in 10 ml of DI water (100X).
Commercial polymyxin B (300 μg/mL) disks were purchased from Carolina Biological.
The antibiotics were stored in a 4°C fridge.
c. Wash (W)
The wash that is currently used for irrigation was prepared by combining 10 ml of 0.9 %
saline with 1.57 ml of 0.25% sodium hypochlorite and 0.3 ml povidone iodine (Dynarex).
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5. The Effects of Current treatment and ECGG-S on inhibition of PJI
a. Kirby-Bauer Disk Diffusion Test
Bacteria were swabbed throughout an MHA plate. Sterile 6 mm diameter BBL TM
disks were then soaked in 1mL of the appropriate surgical wash solution for 1 minute
(saline, sodium hypochlorite and povidone iodine (Wash, W)). A 12 well plate was used
to soak the disks, the disks were removed from solution after 1 minute and allowed to
slightly air dry in an empty well. The disks were then placed aseptically on a MHA plate.
Disks for antibiotics and tea were also prepared by soaking sterile 6 mm BBL TM
disks in solution for 1 minute and allowing it to air dry for the same time frame. A
concentration of 100X antibiotics was obtained from the original prepared stock.
Concentration of 10X antibiotics was prepared by obtaining 100 μl of stock antibiotics
and adding it to 900 μl of DI water. Concentration of 1X was prepared by obtaining 100
μl of 10X antibiotics and adding it to 900 μl of DI water. One ml of 250 μg /ml and 500
μg /ml of EGCG-S were taken from the stock. BPT (bacitracin, polymyxin and tea)
solution was prepared by combining 350 μl of DI H2O, 50 μl of 10X bacitracin, 50 μl of
10X polymyxin B and 50 μl of 250 μg/ml EGCG-S. Commercial Polymyxin B 300 μg
(PC, PB300) was purchased from Carolina Biological.
b. Determining Optimal Time for Treatments
Overnight cultures for S.aureus and S. epidermidis were treated for 30 seconds, 1 minute,
5 minutes, 30 minutes and 1 hour. 100 μl of the overnight culture was removed from a 15
ml tube and placed into an Eppendorf tube, centrifuged and the supernatant was removed.
This was done separately for both organisms. There were a total of fifteen Eppendorf
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tubes each (5 different time intervals and three treatment conditions). The treatments
were Wash (saline, povidone iodine and sodium hypochlorite (W)), WPB (wash,
polymyxin B and bacitracin) and WPBT (wash, polymyxin B, bacitracin and 250 μg
EGCG-S) . For the wash condition 70 μl was prepared and combined with 30 μl of broth.
WBP was made by mixing 70 μl of wash, 10 μl of 10X stock bacitracin, 10 μl of 10X
stock polymyxin B and 10 μl of broth. WPBT solution was prepared by adding 70 μl of
W, 10 μl of 10X bacitracin, 10 μl of 10X polymyxin B and 10 μl (10X 250 μg /ml). Once
the treatments were added to the Eppendorf tube with the microorganism, a timer was set.
At the end of each time interval, 100 μl of the microorganism was removed and spread
aseptically on a TSA plate. The plates were then incubated at 37°C and checked the
following day.
c. Colony Forming Units (CFU) Assay
Overnight cultures for S. aureus and S. epidermidis were made. The optical density (OD)
was measured the next day by putting 1 ml of the overnight culture into a cuvette and
taking a reading with a Spectronic 20 at 600 nm. The overnight cultures were diluted with
broth until an OD of 0.2 was reached. 50 μl of cells (OD 0.2) were transferred to an
Eppendorf tube and centrifuged at 5,000 rpm for 10 minutes. The supernatant was
removed, and treatments were added to the pellet. A control group was constructed by
adding 100 μl of broth to the pellet. The treatment groups WPB and WPBT were
prepared by mixing 80 μl of W+ 10 μl of P + 10 μl of B (WPB), 70 μl of W + 10 μl of P
+ 10 μl of B + 10 μl of T (WPBT). Once treatments were placed on the cells, the
Eppendorf tubes were vortexed. A timer was then set for 1 hour. When an hour of
treatment was finished serial dilutions were carried out. The dilutions were 10-2, 10-3 and
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10-4. The first dilution (10-2) was done by removing 10 μl of cells from the Eppendorf
tube that had the treated cells and putting it into 990 μl of DI H2O. Ten μl was then taken
from 10-2 and added to 990 μl of DI H2O for 10-3 dilution from 10-3 dilution 10 μl was
removed and added to another tube with 990 μl of H2O for a 10-4 dilution. The tubes were
vortexed after each dilution step. Volumes of 100 μl of 10-3 and 10-4 were plated and
spread on TSA plates. The plates were taped and incubated at 37°C, results were recorded
the next day. The colonies were counted, and percent inhibition was calculated by the
following formula:
 

      
  
 

d. Colony Forming Units for Four-time Intervals
Overnight cultures were prepared for S. aureus, S. epidermidis and P. aeruginosa. The
conditions for treatment were: control (100 μl saline + 200 μl DI H2O + 100 μl EtOH +
600 μl TSB), WPB (100 μl wash + 100 μl 10X polymyxin B +100 μl 10X bacitracin +
100 μl EtOH + 600 μl TSB), WBPT (100 μl wash + 100 μl 10X of polymyxin B + 100 μl
of 10X bacitracin + 100 μl of 10X 250 μg /ml EGCG-S + 600 μl TSB). Fifty μl of each
microorganism was obtained and put into Eppendorf tubes three times. A combination of
the bacteria was prepared by acquiring 16.6 μl of each microorganism in an Eppendorf
tube with three replicates. After obtaining 50 μl of cells for all conditions, the Eppendorf
tubes with the cells were centrifuged at 13.3 rpm for 10 minutes. The supernatant was
removed and 50 μl of treatment was added for each condition and mixed vigorously. A
timer was set for 1 minute, 5 minutes, 30 minutes and 1 hour. After each time interval, 10
μl of treated cells were removed and put into 990 μl of DI water. Further serial dilutions
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were carried until 10-6 and 10-7. These two dilutions were plated, spread and incubated at
37°C. A countable range of CFU’s were obtained the following day for 10-6 dilution.
Zero colonies were observed for P. aeruginosa; the experiment was repeated and a
dilution of 10-5 was plated.
e. Resazurin Assay for Detection of Biofilm Inhibition
Overnight cultures were prepared for all three microorganisms and diluted to a 0.3 optical
density. The combination of all three bacteria was prepared by combining 1 ml of each of
the diluted stocks for the three organisms in a separate tube. A 96-well plate was used for
this experiment. A positive control was set up for each microorganism (combination
included) by adding 10 μl of DI H2O to 90 μl of bacteria. Negative control consisted of
100 μl of TSB. WPB treatment was set up by taking 70 μl of diluted bacteria,
centrifuging at 13.3 rpm for 10 minutes, removing the supernatant and adding 10 μl of
Wash, Polymyxin B and Bacitracin. 70 μl of diluted cells for WPBT were also obtained
and centrifuged for 10 minutes. The supernatant was removed and 10 μl of wash,
polymyxin B, bacitracin and 10X 250 μg /ml EGCG-S were added to the pellet and
vortexed; the mixed sample was then pipetted to a well. Three repeats were done for
each condition. After all conditions were set up, parafilm was added to the 96 well plate.
The plate was placed in the 37°C incubator and biofilm was allowed to grow for four
days. The suspension was removed from the plate. After removing the liquid, the wells
were washed with 100 μl of 1X PBS. A 1X stock of resazurin was prepared by diluting 1
ml of 2mM stock (5 mg resazurin powder + 10 ml of 1x PBS) with 9 ml of PBS. 120 μl
of resazurin was added to each sample. The plate was then covered with aluminum foil
and left in a 4°C for 24 hours to allow a full reaction to take place. The next day a
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microplate reader was used to measure fluorescence with excitation and emission
wavelength at 560 nm and 590 nm respectively. Relative light units (RLU) were
measured and percent inhibition was calculated according to the following formula:
 



 
  
 


6. Virulent Factors
a. Protease Assay
Protease assay protocols were modified from a previous study completed by Tran et al
(2014). Overnight cultures were prepared and diluted to 0.1, 0.3, and 0.6 at OD600. of
Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, and a
combination of all three were incubated at 37°C for 8-10 hours. For the untreated
condition, 500 μl of cells were used with two repeats per dilution. The treated condition
450 μl of cells were used with 50 μl of 10X 250 μg /ml EGCG-S with two repeats per
dilution. The study was conducted over 4 days. Each day 250 μl of azocasein in buffer
(consisting of 0.05 M TRIS HCl and 0.5 mM CaCl2) was added and incubated at room
temperature for 15 minutes, followed by the addition of 375 μl of 10% trichloroacetic
acid (TCA). The solution was then centrifuged at 10,000 rpm for 10 minutes. The
absorbance of the supernatant was measured with a Tecan Infinite Pro Micro-Plate
Reader at OD400. The calculation for percentage of inhibition was determined using the
following equation: [(control untreated OD400 – treated OD400)/ control untreated OD400)]
X 100.
b. Elastase Assay
Elastase assay protocols were modified from a previous study completed by Tran et al
(2014). Overnight cultures were prepared and diluted to 0.1, 0.3. and 0.6 at OD600. For
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the untreated condition, 500 μl of cells were used with two repeats per dilution. For the
treated condition 450 μl of cells were used with 50 μl of 10X 250 μg /ml EGCG-S with
two repeats per dilution. The study was conducted over 4 days. Each day 50 μl of
supernatant from the untreated and treated cells were added into 450 μl of Elastin Congo
Red Buffer (ECR) (consisting of 100 mM Tris and 1 mM CaCl2 at pH 7.5) containing 10
mg of ECR and incubated with shaking at 37°C for 3 hours. After three hours, the
reaction was stopped by adding 500 μl of 0.7 M sodium phosphate buffer (pH 6.0). Tubes
were then placed in an ice water bath at 4°C for 15 minutes and centrifuged to remove the
insoluble ECR. The absorbance of the supernatant was measured with a Tecan Infinite
Pro Micro-Plate Reader at OD495. Calculation for percentage of inhibition was
determined using the following equation: [(control untreated OD495 – treated OD495)/
control OD495)] X 100.
c. Evaluation of the Current Treatment with and without EGCG-S
The same procedure for protease and elastase assay as mentioned above was followed for
this study. Overnight cultures were prepared and diluted to an OD of 0.6. Two
replications were made for each condition, for 4 days. The four conditions were control,
wash (W), wash with polymyxin B (P) and bacitracin (B) (WPB), and wash with PB and
250 μg /mL EGCG-S (WPBT). Each condition had 350 μl of the respective cells. The
control condition consisted of 150 μl of H2O. The wash condition had 56.5 μl of saline,
78.5 μl of sodium hypochlorite, and 15 μl of povidone. The wash with PB solution
consisted of 50 μl of saline, 78.5 μl of Dakin’s, 15 μl of povidone, 5μl of 100X
polymyxin, and 5μL of 100X of bacitracin. The wash with PB and Tea solution consisted
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of 55 μl of saline, 78.5 μl of sodium hypochlorite, 15 μl of povidone, 5μl of 100X
polymyxin and bacitracin, and 50μl of 10X 250 μg /mL EGCG-S.
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Results and Discussion
This study consisted of the use of three microorganisms: Gram positive bacteria:
Staphylococcus aureus and Staphylococcus epidermidis; and Gram-negative bacteria
Pseudomonas aeruginosa. These three bacteria are known to be the most prominent
during the pathogenesis of prosthetic joint infections (PJI). Several experiments were
carried out to establish the potential usage of EGCG-S with current methods to enhance
the treatment of PJIs.
1. Gram Stain and Morphological Arrangement of Three Bacteria
Gram stain is a technique used to divide bacteria into two groups. Clinically, it can be
used as a rapid diagnostic test. Gram-positive bacteria contain a thick peptidoglycan layer
along their cell wall. During the staining process they retain the primary dye; crystal
violet. Figures 1a and 1b show Staphylococcus aureus and Staphylococcus epidermidis as
being gram positive (purple) cocci, with grape-like clusters. Pseudomonas aeruginosa
shown in Figure 1 represents the characteristics of a gram-negative species (pink/red).
The observed morphology of P.aeruginosa are single pink/red bacilli. Gram negative
bacteria have a thinner peptidoglycan layer than gram-positive bacteria, due to this
characteristic they are unable to retain the primary dye during the decolorization process;
therefore, acquiring the secondary stain safranin. Gram-negative species are noted as
being more pathogenic than gram-positive species, they contain an additional outer
membrane. This extra layer of protection acts as a virulent factor; releasing endotoxins
(Thairu, Nasir, & Usman, 2014). It is important to know the gram status of bacteria as
they may respond differently to treatments.
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2. Disk Diffusion Test
Disk diffusion test to measure the zone of inhibition (ZOI) was used to evaluate
the effectiveness of different compounds used for treating PJI. The purpose of the first
disk diffusion test was to measure the effectiveness of the surgical wash components
(wash, saline, povidone and sodium hypochlorite) on inhibiting cell growth (Figures 2-5).
For S. aureus, S. epidermidis, P. aeruginosa and a combination of all three; saline and
wash (saline, povidone and sodium hypochlorite combined) had no effect on any of the
microorganisms. Povidone worked the best for S. aureus and S. epidermidis with a ZOI
of 20.5 mm and 21mm respectively; followed by sodium hypochlorite, ZOI 12 mm (S.
aureus) and 12.5 mm (S.epidermidis). Sodium hypochlorite worked slightly better
(11mm) than povidone (10 mm) on P. aeruginosa. For the combination of all three
bacteria povidone and sodium hypochlorite exhibited similar results for ZOI with
P.aeruginosa, having ZOI 21 mm for povidone and 12.5 mm sodium hypochlorite.
Povidone and sodium hypochlorite have the best inhibitory effect. These data suggest that
perhaps some of the components that make up the wash should be increased to a higher
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concentration or exchanged (particularly saline) with another compound that has greater
antibacterial capability.
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Figure 2. Zone of Inhibition Method for S. aureus with the use of Surgical Wash
Components. The zone of inhibition was measured for a disk containing all the surgical
wash components (Wash) and a disk containing those components separately. A 6 mm
measurement was the length of the disk itself, indication that no inhibition occurred.
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Figure 3. Zone of Inhibition Method for S. epidermidis with the use of Surgical
Wash Components. The zone of inhibition was measured for a disk containing all the
surgical wash components (Wash) and a disk containing those components separately. A
6 mm measurement was the length of the disk itself, indication that no inhibition
occurred.
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Figure 4. Zone of Inhibition Method for P. aeruginosa with the use of Surgical Wash
Components. The zone of inhibition was measured for a disk containing all the surgical
wash components (Wash) and a disk containing those components separately. A 6 mm
measurement was the length of the disk itself, indication that no inhibition occurred.
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Figure 5. Zone of Inhibition Method for all three bacteria with the application of
Surgical Wash Components. The zone of inhibition was measured for a disk containing
all the surgical wash components (Wash) and a disk containing those components
separately. A 6 mm measurement was the length of the disk itself, indication that no
inhibition occurred.
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The second disk diffusion study surveyed the current antibiotics used in treating
joint infections and the tea polyphenol EGCG-S (Figures 6-9). Disk diffusion results
using ZOI for the evaluation of the antibacterial effectiveness were divided into three
categories: susceptible, intermediate and resistant as see in table 1. In this study the
current surgical concentration for Polymyxin B (19.8 mg/10 ml) and Bacitracin (22.5
mg/10 ml) were measured and represented as 100X. A concentration of 10X and 1X were
also made. For S. aureus (Figure 6) 100X bacitracin worked well in inhibiting the
bacteria, the ZOI was large enough for the microorganism to be considered susceptible. S.
aureus was resistant to three concentrations of polymyxin B (100x, 10x and 1x). An
intermediate measurement for ZOI was shown for commercial polymyxin B (300 μg) on
S. aureus. When EGCG-S was added to the 100X concentration of bacitracin and
polymyxin B (BPT) the bacteria were susceptible. This study suggested that EGCG-S
may have enhanced the activity of polymyxin B. To further test this, a combination of
polymyxin B with EGCG-S and polymyxin B with bacitracin would have to be
examined. The current concentration of bacitracin had an intermediate effect on targeting
S. epidermidis (Figure 7). A small zone of inhibition was seen when a concentration of
100X polymyxin was used. This small zone of inhibition was not significant and still fell
under the resistant category. Commercial polymyxin B displayed results for antimicrobial
susceptibility. Previous studies, showed that commercial bacitracin (10 μg) on S.
epidermidis had sensitive results (18 mm zone of inhibition). The data gathered here can
lead us to infer that the concentrations used in treatment when targeting a population of S.
epidermidis are not effective. Antibiotic treatments used to treat P. aeruginosa are also
not effective. The only outcome for antimicrobial susceptibility was seen for the
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commercial polymyxin B; an intermediate inhibition rate was observed for polymyxin
100X. The combination of all three bacteria (Figure 9) showed similar results to P.
aeruginosa. The difference between the two was that when the antibiotics were combined
with EGCG-S, we saw the largest zone of inhibition. Further testing for the combination
group would involve examining EGCG-S’s effect on polymyxin and bacitracin
separately. Commercial polymyxin B also worked better at inhibiting the growth of
bacteria than the prepared 100X, 10X and 1X concentrations. The concentration of the
commercial polymyxin B was much lower hence, the opposite effect should have been
seen. Examination of the preparation of commercial polymyxin would also have to be
studied to understand why a larger ZOI is produced in comparison to samples that were
prepared at a higher concentration.
Table 1. Measurements and color code for antibiotics.
Bacitracin

Polymyxin B

Susceptible

Susceptible

>13 mm
Intermediate

>12 mm
Intermediate

9-11 mm

9-11mm

Resistant

Resistant

< 8 mm

< 8mm
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Figure 6. Zone of inhibition for current antibiotic treatment in addition to tea
polyphenols for S. aureus. The current surgical concentration for Polymyxin B (19.8
g/10 ml) and Bacitracin (22.5 g/10 ml) were measured and represented as 100X. 10X and
1x were also observed. The effects of EGCG-S at a concentration of 250 μg /ml and 500
μg / ml can also be seen. The current concentration of polymyxin B and bacitracin were
combined with 250 μg / ml EGCG-S, (BPT). A commercial disk of polymyxin (300 μg)
(PC) was also tested.
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Figure 7. Zone of inhibition for current antibiotic treatment in addition to tea
polyphenols for S. epidermidis. The current surgical concentrations for Polymyxin B
(19.8 g/10 ml) and Bacitracin (22.5 g/10 ml) were measured and represented as 100x. 10x
and 1x were also observed. The effects of EGCG-S at a concentration of 250 μg /ml and
500 μg /ml can also be seen. The current concentration of polymyxin B and bacitracin
were combined with 250 μg / ml EGCG-S, (BPT). A commercial disk of polymyxin (300
μg) (PC) was also tested.
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Figure 8. Zone of inhibition for current antibiotic treatment in addition to tea
polyphenols for P. aeruginosa. The current surgical concentration for Polymyxin B
(19.8 g/10 ml) and Bacitracin (22.5 g/10 ml) were measured and represented as 100x. 10x
and 1x were also observed. The effects of EGCG-S at a concentration of 250 μg /ml and
500 μg / ml can also be seen. The current concentration of polymyxin B and bacitracin
were combined with 250 μg /ml EGCG-S, (BPT). A commercial disk of polymyxin (300
μg) (PC) was also tested.
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Figure 9. Zone of inhibition for current antibiotic treatment in addition to tea
polyphenols for three bacteria. The current surgical concentration for Polymyxin B
(19.8 g/10 ml) and Bacitracin (22.5 g/10 ml) were measured and represented as 100x. 10x
and 1x were also observed. The effects of EGCG-S at a concentration of 250 μg /ml and
500 μg / ml can also be seen. The current concentration of polymyxin B and bacitracin
were combined with 250 μg / ml EGCG-S, (BPT). A commercial disk of polymyxin (300
μg) (PC) was also tested.
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3. Timed Course Study to Evaluate the Effectiveness of Different Treatments
used for PJI
Overnight cultures for S. aureus and S. epidermidis were prepared to determine the
time that would be most effective when administering treatment and to also assess
whether EGCG-S had any observable differences when combined with the current
treatment. Figures 10a and 10b show that at 30 seconds and 1 minute for both organisms
in all the treatment groups, the plates are almost confluent indicating that these times are
not effective when treating PJIs. At 5 minutes, wash did not make any difference for both
organisms; a large difference can be seen between both organisms, especially with WPB
(wash, polymyxin B & bacitracin) and WPBT (wash, polymyxin B, bacitracin and 250 μg
/ml EGCG-S) used on S. epidermidis. This time frame also allows us to be able to count
the colonies and compare, WPBT has a remarkable difference when compared with the
current treatment. At 30 minutes and 1 hour a similar trend can be seen with the least
number of colonies being observed for WPBT. The number of colonies also continues to
decrease as time increases for WPB and WPBT. For one-hour treatment with WPBT,
there is only one colony observed on the plate for S.epidermidis From these results we
can infer that the current time restraint, usually a few seconds is not efficient at targeting
bacterial species. Five minutes is the minimum time for antibiotics and EGCG-S to be
most advantageous. Addition of EGCG-S indicated its synergistic inhibition effect on the
current treatment.
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A.

B.

C.

Figure 10. Determination of Optimal Time Period for Treatment. (a) S.
aureus treated with Wash, WPB and WPBT for 30 seconds, 1 minute, 5 minutes,
30 minutes and 1 hour. The bacteria were then grown on tryptic soy agar plates.
(b). S. epidermidis treated with Wash, WPB and WPBT for 30 seconds, 1 minute,
5 minutes, 30 minutes and 1 hour. The bacteria were then grown on tryptic soy
agar plates. (c). The table exhibits the times and treatment conditions that colonies
were able to be counted.
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4. Colony Forming Units (CFU) Assay
This experiment was done as a quantitative method to allow us to measure cell
viability and further measure the enhancing capabilities of EGCG-S on current PJI
treatment. The cells were treated with wash, WPB and WPBT for one hour. The control
group had no treatment, cells were resuspended in broth. After treatment the cells were
plated on tryptic soy agar (TSA) plates. Figure 11 shows that for S. aureus, the wash had
a 98% inhibition followed by 100% with the addition of polymyxin and bacitracin. When
EGCG-S was added to the wash in combination with polymyxin and bacitracin a 100%
inhibition was also observed. Similar results were observed for S. epidermidis and P.
aeruginosa, (Figure 12 and Figure 13, respectively). The wash results varied between
these two organisms (S.epidermidis and P.aeruginosa); a 93% inhibition for S.
epidermidis and 62% inhibition for P. aeruginosa were also observed. For one-hour
treatment, the effect of WBP and WBPT did not show any difference for the CFU assay
(0 CFU). Further experiments would involve conducting the experiment with lower
dilutions at the one-hour time frame. This could possibly allow us to obtain a countable
range and determine whether there is a major difference when EGCG-S is added to the
two antibiotics.
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Figure 13. The Effect of Surgical Wash Components with the Addition of
EGCG-S on CFU for P. aeruginosa (a). Tryptic soy agar plates that the bacteria
were grown on, colony forming units can be seen on the control and wash plate.
WBP (wash, polymyxin and bacitracin) and WBPT (wash, bacitracin and
polymyxin) plates appear to be transparent with no colony forming units. (b).
Table shows the total plate count for each condition. (c). Percent inhibition for the
treated groups.

43

An additional CFU assay was done for the time course study. It involved
expanding on the results obtained in Figure 10. The two treatments that were shown to
have the most effect on cell viability, WPB and WPBT, were used. In addition to S.
aureus and S. epidermidis; P. aeruginosa and a combination of all three bacteria were
also examined. The results show that for S. aureus EGCG-S had the most synergistic
effect at the 1-hour mark with bacitracin and polymyxin (Figure 14). At 30 minutes
EGCG-S with WBP also had a higher percent inhibition than WBP alone at that same
time frame. A large standard deviation was present for WPB which suggested that data
acquired is not reliable. At 5 minutes the tea polyphenol is seen to have no effect and at
the 1-minute time frame WPB works slightly better. EGCG-S in combination with WPB
is shown to have higher inhibitory effect for S. epidermidis at 5 minutes, 30 minutes and
1 hour. P. aeruginosa is impacted the most by EGCG-S at 1-hour treatment time (Figures
15 and 16). At 1 minute and 5 minutes WPB seems to have the most progress. When all
the bacteria were grown together, EGCG-S had the best synergistic effect at 30 minutes
and 1 hour (Figure 17). WPB worked better than WPBT at 1minute and 5 minutes. From
the results obtained in Figure 10, it was expected that as time increased, the more cell
death there would be and treatment with the addition of EGCG-S would have prime
results. This trend is strictly not observed for S.aureus, P.aeruginosa and combination.
Possible reasons for this could be that the population of cells was not consistent for the
organisms resulting in fluctuating data. Dilution errors could have also played a role. A
higher serial dilution was also used for this study, when compared to the results obtained
for the effect of surgical wash components with the addition of EGCG-S on CFU (Figure
10) the results contradict; a dilution of 10-3 performed and the outcome was 0 colonies.
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For timed treatment (Figures 14-17), a dilution of 10-3 was too low; 10-6 gave us the
countable range. Future studies will involve starting with the same optical density for all
cell populations and repeating the four-time frames to determine if treatment with the
addition of EGCG-S is able to enhance the activity of the current treatment.
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Figure 14. S. aureus CFU for Timed Treatments. S. aureus treated with WPB and
WPBT for 1 minute, 5 minutes, 30 minutes and 1 hour. Treated cells were diluted to 10-6.

Figure 15. S. epidermidis CFU for Timed Treatments. S. epidermidis treated with
WPB and WPBT for 1 minute, 5 minutes, 30 minutes and 1 hour. Once treated cells were
diluted to 10-6.
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Figure 16. P. aeruginosa CFU for Timed Treatments. P. aeruginosa treated with WPB
and WPBT for 1 minute, 5 minutes, 30 minutes and 1 hour. Treated cells were diluted to
10-5.

Figure 17. S. aureus, S. epidermidis and P. aeruginosa CFUs Timed Treatments. 1/3
of each bacterium were combined and treated WPB and WPBT. The treatment times
were 1 minute, 5 minutes, 30 minutes and 1 hour. Treated cells were diluted to 10-5.
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5. Resazurin Assay for the Inhibition of Biofilm
Resazurin is a non-toxic stable stain used to measure cell viability. Cells that are
metabolically active reduce non-fluorescent resazurin to the fluorescent product resorufin
(Van den Driessche, Rigole, Brackman & Coenye, 2013). Results shown in Figure 18
indicate that WPBT is just as effective as WPB at treating biofilms caused by S. aureus
and S. epidermidis. EGCG-S is shown as having a more considerable synergistic effect
on P. aeruginosa biofilm than with WPB alone. For the combination treatment WPB has
a slightly greater outcome than WPBT. Previous studies have shown the biofilm caused
by P. aeruginosa to be the most difficult to treat (Chen, 2016). From our findings P.
aeruginosa has been noted to rapidly accumulate and dominate a population when other
microorganisms are present. This study suggests that EGCG-S can play a crucial role in
targeting biofilms caused by P. aeruginosa.

Figure 18. Resazurin Assay. The three predominant microorganisms in PJI were
examined separately and in combination for biofilm inhibition. The two treatments used
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to target the biofilm were WPB (wash, polymyxin B and bacitracin) and WPBT (wash,
polymyxin, bacitracin and 250 μg EGCG-S).
6. Virulent Factors
Quorum sensing is a technique that gram-negative and positive bacteria use for
group behavior. Autoinducers are released for communication allowing the population to
persist and grow (Raffa et al., 2004). Protease and elastase are proteolytic enzymes that
allow bacteria to invade colonize a host’s tissue (Tran et., al). A compound that targets
these enzymes could eliminate the destructiveness caused to the host.
Protease production was measured for the prominent microorganisms involved in
causing prosthetic joint infection. Three optical densities were used to determine whether
the production of protease is cell population dependent. Protease readings were taken
during the course of four days to determine if biofilm density has any effect in the
amount of protease production for each of the groups (S. aureus, S. epidermidis, P.
aeruginosa and combination). The results are shown in Figures 19-22. Optical density of
cells did not have a significant effect on the amount of protease production. For S.
aureus, S. epidermidis and P. aeruginosa the amount of protease output increased on the
first day and stayed consistent for days 2-4. When all three bacteria were combined, the
greatest amount of protease production was during day 2. The amount of protease
measured for the bacteria in combination was much more substantial than when the
bacteria were existing amongst their own population. The results indicate that when the
bacteria are in combination, the enzyme is enhanced. This mimics what would happen in
a joint infection that has more than one species. The effect of EGCG-S was measured for
bacteria that had been treated for two and four days (Figure 23). The most notable %
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inhibition was observed for the bacteria in combination (Table 2). The % of inhibition
was 78.03 % and 76.79 % for day 2 and day 4, respectively.

Figure 19. Protease assay for S. aureus during the course of four days. The
production of protease was measured under three optical densities (0.1, 0.3 and 0.6).

Figure 20. Protease assay for S. epidermidis during the course of four days. The
production of protease was measured under three optical densities (0.1, 0.3 and 0.6) for
the microorganism.
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Figure 21. Protease assay for P. aeruginosa during the course of four days. The
production of protease was measured under three optical densities (0.1, 0.3 and 0.6) for
the microorganism.

Figure 22. Protease assay for the combination of the three bacteria during the
course of four days. The production of protease was measured under three optical
densities (0.1, 0.3 and 0.6) for the microorganisms.
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Figure 23. The use of EGCG-S to inhibit protease production. EGCG-S was used on
bacteria grown for two and four days and compared against bacteria that were grown
without it for the same number of days. The groups of bacteria were PA (P. aeruginosa),
S. epidermidis (SE), S. aureus (SA) and Combo (S. aureus, S. epidermidis and P.
aeruginosa). An optical density of 0.6 was used.
Table 2. The percent inhibition of protease production during Day 2 and day 4. Bacteria
were treated with EGCG-S.
Bacteria

Day 2

Day 4

Pseudomonas aeruginosa

19.26 %

0%

Staphylococcus aureus

30.10 %

20.20 %

Staphylococcus epidermis

30.44 %

0%

Combination

78.03 %

76.79 %
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The production of elastase was also measured for the three bacteria (Figures 2427). Optical density did not seem to have a significant effect on the production of the
enzyme. The amount of enzyme production stayed consistent throughout four days for S.
aureus, S. epidermidis and P. aeruginosa. The combination of bacteria produced a
considerable amount of elastase after day 1 of growth. EGCG-S was used to inhibit
elastase production and the results were measured after two days (Figure 28). The
greatest effect of percent inhibition was seen for the bacteria in combination with 77.09
%. (Table 3). The results suggested that the production of enzymes (virulent factors) are
enhanced when the bacteria are in competition.
EGCG-S had an effect on inhibiting protease and elastase production. The next
goal was to examine if it could work with the current treatment to prevent or reduce the
production of virulent factors. Percent inhibition for W, WBP, and WBPT for P.
aeruginosa and a combination of all three bacteria are shown in Figure 29 and 30. The
results showed EGCG-S having little to no difference from the other two groups (Wash &
Wash+PB). EGCG-S was seen to work better by itself when not combined with wash or
antibiotics. Further studies would have to be done to determine why EGCG-S does not
have an inhibitory effect when combined with the current surgical wash and antibiotics.
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Figure 24. Elastase Assay for S. aureus during the course of four days. The
production of elastase was measured under three optical densities (0.1, 0.3 and 0.6) for
the microorganism.

Figure 25. Elastase Assay for S. epidermidis during the course of four days. The
production of elastase was measured under three optical densities (0.1, 0.3 and 0.6) for
the microorganism.
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Figure 26. Elastase Assay for P. aeruginosa during the course of four days. The
production of elastase was measured under three optical densities (0.1, 0.3 and 0.6) for
the microorganism.

Figure 27. Elastase assay for the combination of S. aureus, S. epidermidis and P.
aeruginosa the course of four days. The production of elastase was measured under
three optical densities (0.1, 0.3 and 0.6) for the microorganism.
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Figure 28. Inhibition of Elastase by EGCG-S after two days of growth. EGCG-S was
used on bacteria grown for two and four days and compared against bacteria that were
grown without it for the same number of days. The groups of bacteria were PA (P.
aeruginosa), SE (S. epidermidis) SA (S. aureus) and Combo (S. aureus, S. epidermidis
and P. aeruginosa). An optical density of 0.6 was used.
Table 3. Percent of inhibition of Elastase production during Day 2 of treatment
with EGCG-S
Bacteria

Day 2

Pseudomonas aeruginosa

54.87 %

Staphylococcus aureus

26.16 %

Staphylococcus epidermidis

0%

Combination

77.09 %
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Figure 29. Percent Inhibition of protease for P. aeruginosa when treated with
current treatment for infection and with the addition of EGCG-S. Optical density for
the microorganism was prepared at 0.6. The bacteria were grown and treated for 1-4
days.
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Figure 30. Percent Inhibition of protease production for the combination of three
bacteria when treated with current treatment for joint infection and with the
addition of EGCG-S. Optical density for the microorganisms were prepared at 0.6. The
bacteria were grown and treated for 1-4 days.
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Conclusions
Previous studies established 250 μg /ml EGCG-S as being the minimum
inhibitory concentration for working against S. aureus, S. epidermidis an d P.aeruginosa.
It was also established that EGCG-S could be a used during irrigation after implant has
been placed; to prevent infection from occurring. Data gathered from this study looks at
methods in which EGCG-S can be used for infections that have occurred due to implant
surgery.
A survey of the current prosthetic joint wash protocol was examined; EGCG-S
was used in combination to determine whether it could enhance the outcome. EGCG-S
with current wash and antibiotics were shown to have some inhibitory effects for colony
forming units. In treating a large population of S.aureus and S. epidermidis; 5 minutes
was shown to be the start of treatment that would have the most beneficial effect. Other
studies showed that for a serial diluted population of S. aureus, S.epidermidis,
P.aeruginosa and a combination of all three ECGG-S had the most effect at the 30
minutes and 1 hour.
For inhibition of biofilm EGCG-S was shown to be just as effective when
combined with wash and antibiotics for S.aureus and S.epidermidis. EGCG-S had a slight
advantage in targeting biofilm caused by P.aeruginosa. Protease and elastase enzymes
were seen to be produced predominantly when all three bacteria were existing together.
EGCG-S worked to a greater extent for the combination of all three bacteria when it was
used alone and not combined with the current treatment.
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This study shows EGCG-S as having the possibility of improving the current
treatment method by targeting acute infections formed by planktonic cells and providing
an alternative method for chronic infections caused by biofilms.
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Future Studies
The mechanism of action for how EGCG-S targets bacterial cells and biofilm will
need to be further understood. The different genes detected for specific species as being
responsible for biofilm and the pathogenicity of the bacteria will have to be further
analyzed by PCR and/or qPCR to determine if EGCG-S plays a role in down-regulating
the expression.
EGCG-S with the use of a single antibiotic would also have to be further
examined to determine whether the same or greater effects can be observed when the
antibiotics are not in combination. Different combinations of antibiotics will also be
studied to determine the minimum inhibitory concentration that can be used with EGCGS. Once this is established an examination of infected tissue culture and implant material
will be studied.
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Appendix A | Nanodrop Readings

DNA
Extraction

260/280

260/230

ng/

1.99

1.01

816.1

1.90

1.21

Staphylococcus
aureus

Staphylococcus
epidermidis

1042.8
Pseudomonas
aeruginosa
1.86

0.97

764.5

Appendix A. Nanodrop readings. DNA was extracted from S. aureus, S. epidermidis
and P. aeruginosa. Column two shows the ratio of DNA to RNA (260/280). Column
three ratio of DNA to impurities (260/230) and Column four has the concentration of
DNA in ng/ μl. The DNA was stored and used with species specific primers to check for
the presence of certain genes.
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Appendix B | Staphylococcus aureus primers for sequence analysis
Staphylococcus aureus
Gene

Sequence 5’-3’

Tm
(°C)

PCR/qPCR

Function

16s_rRNA_F_SA

TGTCGTGAGATGTTGGG

57.2

qPCR

16s RNA

16s_rRNA_R_SA

CGATTCCAGCTTCATGT

58.4

qPCR

16s RNA

clfA_F

AGAAACGCCGGTAACT

54.2

qPCR

clfA_R

CTCTCA TTCTAGGCGCAC

59.9

qPCR

clfB_F

GCGCATTGGAAATCGT

54.2

qPCR

clfB_R

AGAGCCAGCTTCAACA

54.2

qPCR

FnbA_F

ATGA TCGTTGTTGGGATG

55.3

PCR

FnbA_R

GCAGTTTGTGGTGCTTGT

57.6

PCR

FnbB_F

ACAAGTAATGGTGGGTAC

55.3

PCR

FnbB_R

AATAAGGATAGTATGGGT

50.1

PCR

IcaA_F

TTTGGGTGTCTTCACTCTAT

58.7

PCR

IcaA_R

60.6

PCR

IcaR_F

CCTAGTAATACTTCGTGTCC
C
ATCTAATACGCCTGAGGA

55.3

PCR

IcaR_R

TTCTTCCACTGCTCCA

54.8

PCR

spa_F

TTTGTCAGCAGTAGTGCC

57.6

PCR

spa_R

ACGA TCCTTCAGTGAGC

57.2

PCR

Clumping
factor
Clumping
factor
Clumping
factor
Clumping
factor
Fibronectin
binding
protein
Fibronectin
binding
protein
Fibronectin
binding
protein
Fibronectin
binding
protein
Slime
production
Slime
production
Transcriptiona
l repressor
Transcriptiona
l repressor
Allows SA to
invade host
immune
system
Allows SA to
invade host
68

immune
system
Appendix B. Primers for S.aureus. Forward primer is abbreviated with F and reverse
with R. Annealing temperature and the gene function are also provided.
Appendix C | Staphylococcus epidermidis primers for sequence analysis
Staphylococcus epidermidis

Aap1_F

ATATGGGCAAACGTAGACAAGTC

Tm
(°C)
62

Aap1_R

AGTTGGCGGTATATCTATTGTA

64.6

PCR

Aap2_F

GAAGCACCGAATGTTCCAACTAT
C

62.9

PCR

Aap2_R

TGGTTCTGCTTTTGTTGGACCATA
C

62.9

PCR

icaADB_F

TTATCAATGCCGCAGTTGTC

70.8

PCR

icaADB_R

GTTTAACGCGAGTGCGCTAT

60.4

PCR

Gene

Sequence

PCR/qPCR

Function

PCR

Subunits for
intracellular
lipid kinases
Subunits for
intracellular
lipid kinases
Subunits for
intracellular
lipid kinases
Subunits for
intracellular
lipid kinases
Biofilm
producing
ability
Biofilm
producing
ability

Appendix C. Primers for S. epidermidis. Forward primer is abbreviated with F and
reverse with R. Annealing temperature and the gene function are also provided.
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Appendix D | Pseudomonas aeruginosa primers for sequence analysis
Pseudomonas aeruginosa
Gene
16s_rRNA_PA_F

Tm PCR/qPCR Function
(°C)
CAAAACTACTGAGCTAGAGTACG 61
PCR
16sRNA
Sequence

16s_rRNA_PA_R GCCACTGGTGTTCCTTCCTA

62.4

PCR

16sRNA

OprL_F

CCAACAGCGGTGCCGTTGA

64.5

qPCR

OprL_R

GCGATATTGTACTCGCGGGT

62.4

qPCR

ToxA_F

GGAGCGCAACTATCCCACT

62.3

qPCR

ToxA_R

TGGTAGCCGACGAACACATA

60.4

qPCR

PA1169_F

GCGGAACAACAGGGTCTA T

60.4

qPCR

PA1169_R

CCTTTGACATTGCCGAAGTT

58.4

qPCR

outer
membrane
integrity
outer
membrane
integrity
Blocks
protein
synthesis
Blocks
protein
synthesis
Protein
coding
lipoxygenase
Protein
coding
lipoxygenase

Appendix D. Primers for P.aeruginosa. Forward primer is abbreviated with F and
reverse with R. Annealing temperature and the gene function are also provided.
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Appendix E | Polymerase chain reaction parameters
Stage

Tm (°C)

Time

Number of Cycles

Denaturation

95

1 minutes

1

Denaturation

95

20 seconds

30

Annealing

Varies

20 seconds

30

Extension

72

1 min

30

Extension and
polishing
Storage

72

7 minutes

1

4

∞

N/A

Appendix E. PCR Parameters. These parameters were used with the primers for
S.aureus, S.epidermidis and P.aeruginosa. Annealing temperature varied according to the
Tm listed for the primer.
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Appendix F | Gel electrophoresis and Sequence protocol

Gel Electrophoresis
A 1% gel agarose was made by measuring out 0.4 g of agarose and dissolving it
in 40 ml of 1x Tris-Acetate-EDTA (TAE) buffer. A 2% gel was prepared by using 0.8 g
of agarose instead of 0.4 g. After the agarose was added to the TAE, it was heated in a
microwave for a few seconds until the agarose fully dissolved. 4 μl of SYBR safe was
added to the solution and swirled gently. This mixture was used to cast a gel, the gel tray
was first placed in the gel box at a 90-degree angle forming a seal. A comb was added to
the front end of the gel tray and one in the middle end of the tray if more than 10 samples
were being used. Once the solution was cool to the touch it was poured into the tray. The
gel was allowed to solidify (approx. 20 minutes). TAE buffer was then poured on top of
the gel until it was fully submerged. The comb/combs were carefully removed. Samples
were prepared for well loading by pipetting 10 μl of PCR product into a clean new tube. 2
μl of loading dye was added to the 10 μl of PCR product and mixed. The full 12 μl was
loaded into a well. The gel was then ran at 115 volts for 30 minutes. Visualization of the
gel took place under a blue transilluminator.
Sequencing and Blast
A sample of the PCR product was sent for sequencing if a band was observed on
the gel. The laboratory and equipment technician at Montclair State University developed
the sequence. Once sequences were acquired a BLAST search was done on the
nucleotides. https://blast.ncbi.nlm.nih.gov/Blast.cgi.
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Appendix G | Gel electrophoresis, Sequence and BLAST results
A.

B.

C.
16s RNA (SE) Primer 3F - 127bps
GCCCCATTCCGCTCGGCATGGGGGTGGTCCAGTTTCGAATGCACCCTCCGCG
GGGGAGCCGTGGGTGTCCGGACAATAATGAGACCCGAGCCGCCGGCGATAA
CGCGAACCCTGAGCGGGGACCCCA
16s RNA (SE) Primer 3F- Blast Search
No significant similarity found
FnbA (SA) Primer 6F - 191bps
GGGGTGCACGTCCAGGAACTACAGTAGAGAATGGGATTCAGCTACTGATAAT
AAAGTAAGCGAAACACAAACAACTACACTAACGTTAATACTATAGATGAAAC
ACAATCATACAGCGCAACAGCCAAAGAACTCCCGTCACACGGTAGAACTGA
GAGCCCGCATTATTTGGCCCCCCCACCGCAGATAAA
FnbA (SA) Primer 6F - Blast Search
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OprL (PA) Primer 7F- 133bps
CAATTCGGGTTTCTTGCTGATTCTGCAGCACGTCGCGCGTCTTTATAGTCAGG
TTGTCATATTGGGCAGAGTCGGCGTAATCAGGTTGTCCAGCGAACTTCGCGA
GGTCCTATGTTCAGGTGTTGTTCCGCA
OprL (PA) Primer 7F- Blast Search
No significant similarity found
Appendix G. Gel electrophoresis, sequence and BLAST search (a). A 1% agarose gel
was made for the primers used on SA (S. aureus), SE (S. epidermidis) and PA (P.
aeruginosa). A band is shown if the gene is present. The first row contains the ladder. A
molecular weight chart is shown to the left of the first well to depict a clearer image of
the molecular weight. (b). The table corresponds to the wells on the gel and what is in
each one. Primers specific to S. aureus, S. epidermidis and P. aeruginosa were obtained.
A 1:10 dilution was made for the primers. Primers highlighted in red represent the gene
being detected in the microorganism. (c) One primer for each microorganism was chosen
for sequencing, afterwards a blast search was done.
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Appendix H | Gel electrophoresis, sequence and BLAST results

C.
SpA (SA) Primer 7F- 298 bps
AGACCAGTACTGTATCACACGCTGACGACATGTACTCCGTTGCCGTCTTCTTT
ACCAGGCTTGTTGCATCTTCTTTACCAGGCTTGTTGCCGTCTTCTTTACCAGGT
TTGTTGCCATCTTCTTTGCCAGGTTTTTTGTTGTCTTCTTTACCAGGTTTGTTGC
CGTCTTCTTTGCCCGGCAAGATGTTGACTTCTTTACAAGAGAGGTAGCGCCCG
TAAGAACTGGAATAGCCTGTTACAGATGCGCTGACTTCTCTGTTGACCTGAGC
TCGTTAATTTTTGCTCGCAAACTTCTTGCTGACAAAAGACGTATC
SpA (SA) Primer 7F Blast Search
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ToxA (PA) Primer 3F (bottom row)- 113 bps
GCATTGGGGCAGGGTTCTATTCAGCCTTTCGCATCGTGCAGCAGACTGGACG
GTGGACGACTGCTGCGCCGTGGCAGTTTCGCACGTGGAATGCGCTATACGTT
CAGCGGGCT
ToxA (PA) Primer 3F (bottom row)- Blast Search
No significant similarity found
Appendix H. Gel electrophoresis. (a). A 2% agarose gel was made for the primers used
on SA (S. aureus), SE (S. epidermidis) and PA (P. aeruginosa). A band (above blue
arrow) is shown if the gene is present. The first row contains the ladder. (b). The table
corresponds to the wells on the gel and what is in each one. Primers specific to S. aureus,
S. epidermidis and P. aeruginosa were used. A 1:10 dilution was made for the primers.
Primers in red represent the gene being detected in the microorganism. (c) One primer
that worked was chosen for each microorganism and sequenced. A blast search was done
with the sequence data.
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Appendix I | Gel electrophoresis, Sequence and BLAST results for Crossmatch of
primers
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FnbA (SA) SE Primer 3F- 210bps
TTGATCCAAATCAGCACAAGACACTACAGTAGAAGAAATGGGAATTCCAGCT
ACTGATAATAAAGTAAGCGAAACACAAACAACTACAACTAACGTTAATACTA
TAGATGAAACACAATCATACAGCGCAACAGCAACAGAACAACCGTCAAACG
CAACACAAGTAACAACTGAAGAAGCACCAAAAGCAGTACAAGCCCCACAAA
CTGC
FnbA (SA) SE Primer 3F -Blast Search
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clfB (SA) SE Primer 4F -180bps
GTGTATCTATGTGAGGATTTTAGCTCACTGTTTGTTGCTATGTTATTAGCATCA
TTCGTTGTTTTATTATCTACTTGAGAATTTGCTTCTTGAGGAACAGTTTGATCT
TGCATTTTTGCAGCAGTTGCTTGATCTTTAATTGCCGTCGGTTGAGGTGTTTCA
TTTGATGAAGCTGGCTCT
clfB (SA) SE -Primer 4F-Blast Search

icaR (SA) SE Primer 6F -180bps
GAGAAGTTTGAAAATACAACTGTGGAGGGGCAGAAAATATTAAATTCTGAAG
TCTTCTTTTGTCATCTTTATTTTTGATTCATCATAGAGTTTGCTATCTCTTTACT
TAGTGGTTGATTTAAATCTTGTATTTATCCGTAAATATTTCCAGAAAATTCCTC
AGGCGTATTAGATA
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icaR (SA) SE Primer 6F -Blast Search

ToxA (PA) SE Primer 7F -178bps
GCTATCGGCGCGGCGCCATCAGCTTCCAGCACCGCGCACGCAGACTGGACGG
TGGAGCGGCTGCTCCAGGCGCACCGCCAACTGGAGGAGCGCGGCTATGTGTT
CGTCGGCTACCTGGG
ToxA (PA) SE Primer 7F-Blast Search
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SpA (SA) SE Primer 9F- 325bps
CGACCAATTACTGCTATCACCAGGTTACGACATGTACTCCGTTGCCGTCTTCT
TTACCAGGCTTGTTGCCATCTTCTTTACCAGGCTTGTTGCCGTCTTCTTTACCA
GGTTTGTTGCCATCTTCTTTGCCAGGTTTTTTGTTGTCTTCTTTACCAGGTTTGT
TGCCGTCTTCTTTGCCAGGTTTTTTGTTGTCTTCTTTACCAGGTTTGTTGCCGTC
TTCTTTACCAGGCTTGTTGTTGTCTTCTTTGCCAGGCTTGTTGTTGTCTTCCTCT
TTTGGTGCTTGAGCATCGTTTAGCTTTTTAGCTTCTGCTAAAATTTATTTGCTC
ACTGAAGGATCGT
SpA (SA) SE Primer 9F- Blast Search

Appendix I. Gel Electrophoresis, Sequences and BLAST search for crossmatch of
primers. (a&c). A crossmatch of primers was done against a primer specific to one
organism and another organism that was not noted to have the gene present. (b&d). The
table corresponds to the primers and their well location on the gel. In parenthesis is the
correct organism for that primer. The abbreviations after the dashed line corresponds to
the organism that the primer was used for. The text in red shows the primers that worked
against their non-specific organism. (e). Primers that worked on the top of gel A (also in
red text in table B) except for clfA were used for sequencing and later put though a blast
search.
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